Which Factors Lifted Babcock & Wilcox (NYSE:BW) by 12.66% Pre-Market on Tuesday?

Vinay Lochav

10 November 2026 11:43 PM AEDT

Which Factors Lifted Babcock & Wilcox (NYSE:BW) by 12.66% Pre-Market on Tuesday?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

Early indications have Babcock & Wilcox (NYSE:BW) at USD 4.27 on November 10, 2026, up 12.66% or USD 0.48 against a calculated prior close of USD 3.79.
Reported third-quarter 2026 sales reached USD 290.8 million, a 109% annual increase, whereas EPS of USD 0.02 was characterised in press coverage as a marginal shortfall.
By calculation, a 109% gain points to prior-year Revenue of about USD 139.1 million, which means roughly USD 151.7 million of extra sales.
The results and the conference call both came out on November 9, 2026, making the November 10 pre-market shift the initial complete market response.

Pre-Market Action at Babcock & Wilcox (+12.66%)

Early quotes for Babcock & Wilcox (NYSE:BW) reached USD 4.27 on Tuesday, November 10, 2026, a 12.66% advance over the calculated Monday, November 9 close of USD 3.79. The USD 0.48 increase came after the company disclosed third-quarter 2026 figures on November 9. Press reports put revenue at USD 290.8 million, a 109% jump on the prior-year quarter, while EPS of USD 0.02 was termed a marginal miss against forecasts by one write-up. On a calculated basis, the revenue rise equates to roughly USD 151.7 million in extra sales compared with the prior-year quarter's approximate USD 139.1 million.

Behind the Rally: Earnings Figures and Market Mechanics

The third-quarter release is the identified driver. Revenue more than doubled, but EPS of USD 0.02 was modest, leaving investors to balance expansion against profitability. Backlog, order intake, outlook and cash data were not obtained in this work and so are not reported here. In general terms, a company with revenue growth in the triple digits may attract buying even after a small EPS shortfall if its outlook or incoming orders look robust, and buying to close short positions can add to the rise. Pre-market sessions are thinner than the regular trading day, so a small batch of orders can shift the indication by a few cents. On a calculated basis, one cent equals about 0.26% of USD 3.79, which means the USD 0.48 gain amounts to 48 such steps.

Valuation, Trading Depth and Risk Factors at Babcock & Wilcox

Market capitalisation, the 52-week range and average Volume could not be verified for this piece, so none appear here, and readers should consult the exchange quote directly. At a share price close to USD 4, the stock falls into the lower-priced bracket, where moves look large in relative terms, and a USD 0.10 change represents roughly 2.3% of USD 4.27, on a calculated basis. Falling back to the calculated prior close of USD 3.79 would mean an 11.2% fall from USD 4.27. Taking a hypothetical USD 10,000 holding, the pre-market rise is worth about USD 1,266, calculated, and a complete Reversal would erase that amount. Bid-ask spreads may be broad before 9:30 a.m. ET, and results marked by big revenue swings can be uneven from one quarter to the next. The 109% growth also comes off a smaller base, which makes repeating that pace harder.

Where Things Stand

Babcock & Wilcox (NYSE:BW) has risen 12.66% pre-market as third-quarter 2026 revenue reached USD 290.8 million, a 109% increase, which attracted buyers even though EPS of USD 0.02 was called a marginal shortfall. The shift from a calculated USD 3.79 to USD 4.27 reflects an early indication on light volume and could unwind at the opening bell. Outlook and order Backlog were not verified in this piece and need confirming against the company's release.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.